“Increased Demand for Non-Invasive and Long-Acting Drug Delivery Method”
- A significant and accelerating trend in the global hyoscine market is the rising preference for non-invasive and long-acting drug delivery methods, particularly transdermal patches. These formats offer extended therapeutic effects and improved patient adherence, especially in the treatment of motion sickness and postoperative nausea
- For instance, scopolamine transdermal patches provide up to 72 hours of continuous symptom relief, making them ideal for travelers and patients requiring long-duration dosing
- The growing popularity of patches is largely due to their convenience, minimal side effects compared to oral formulations, and suitability for patients with swallowing difficulties
- Pharmaceutical companies are increasingly focusing on developing advanced patch technologies with improved adhesion, controlled drug release, and reduced adverse effects, which are driving innovation and product differentiation
- This trend towards convenient, patient-friendly, and effective delivery systems is reshaping treatment protocols and consumer expectations, encouraging companies such as Novartis and GlaxoSmithKline to expand their transdermal product lines to meet growing demand
